Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on

Emiliano Altamura1, Monica Borgatti2, Alessia Finotti2

  • 1Chemistry Department, University of Bari, Bari, Italy.

Plos One
|April 28, 2016
PubMed

Insights

Researchers developed a novel yeast-based dual-fluorescence reporter system to efficiently screen for compounds that can suppress premature termination codons (PTCs). This system accurately quantifies read-through at all three stop codon types, aiding therapeutic development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Nonsense mutations introduce premature termination codons (PTCs) into mRNA, halting protein synthesis and causing disease.
  • Therapeutic strategies aim to restore full-length protein production by inducing read-through of PTCs.
  • High-throughput screening is essential for identifying effective read-through-inducing compounds.

Purpose of the Study:

  • To develop a rapid, sensitive, and quantitative method for monitoring and quantifying read-through at PTCs.
  • To establish a high-throughput screening system for identifying novel PTC read-through agents.
  • To validate the system's efficacy across all three types of stop codons (UGA, UAG, UAA).

Main Methods:

  • Utilized a dual-fluorescence reporter system in Saccharomyces cerevisiae (yeast).
  • Engineered the reporter to express distinct fluorescent proteins based on read-through efficiency at PTCs.
  • Quantified read-through by measuring fluorescence intensity ratios.

Main Results:

  • Demonstrated a rapid, sensitive, and quantitative method for assessing PTC read-through.
  • Successfully detected and quantified read-through at all three major stop codons (UGA, UAG, UAA).
  • Validated the system's suitability for high-throughput screening applications.

Conclusions:

  • The developed dual-fluorescence reporter system in yeast provides an efficient platform for PTC read-through screening.
  • This method facilitates the discovery of novel therapeutics for genetic diseases caused by nonsense mutations.
  • The system's ability to detect read-through at all stop codon types enhances its utility in drug discovery.